Company Filing History:
Years Active: 2023
Title: The Innovations of Kyle Paul Heim
Introduction
Kyle Paul Heim is an accomplished inventor based in Boulder, Colorado. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides related to human cytomegalovirus (CMV). His work has implications for vaccine development and therapeutic interventions.
Latest Patents
Kyle Paul Heim holds a patent for a polypeptide related to human cytomegalovirus gB. The invention pertains to polypeptides and CMV antigens that include at least one introduced amino acid mutation relative to the amino acid sequence of the wild-type HCMV glycoprotein B (gB). In some embodiments, the polypeptide is stabilized in a conformation alternative to the gB postfusion conformation. The patent also discloses compositions that include these polypeptides and their various uses. He has 1 patent to his name.
Career Highlights
Kyle is currently employed at Pfizer Corporation, a leading global biopharmaceutical company. His role involves research and development in the field of virology, where he applies his expertise to advance medical science.
Collaborations
Throughout his career, Kyle has collaborated with notable colleagues, including Philip R. Dormitzer and Ye Che. These partnerships have fostered innovation and contributed to the advancement of their shared research goals.
Conclusion
Kyle Paul Heim is a notable inventor whose work in biotechnology has the potential to impact public health significantly. His contributions to the understanding of human cytomegalovirus and the development of related polypeptides highlight the importance of innovation in the medical field.